Clinical Trial Update: Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating piperacillin-tazobactam and temocillin as carbapenem-sparing options for severe infections due to ESBL-producing Gram-negative Enteroba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)
• Temocillin (temocillin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sepsis, Septic Shock | Phase 3 | Status: RECRUITING